Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
control group:Symptomatic treatment of Western medicine + Jinghua Jiedu decoction placebo
Sponsors
The First Affiliated Hospital to Henan University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Asymptomatic patients with COVID-19; 2. Age 18-80 years old; 3. Voluntarily accept treatment and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. delirious, consciousness disorder, dementia, all kinds of mental patients; 2. Pregnant and lactating women; 3. Patients with active pulmonary tuberculosis, pulmonary abscess and chronic respiratory failure; 4. Patients with tumor; 5. Patients with severe liver and kidney diseases; 6. patients with severe cardiovascular and cerebrovascular diseases; 7. those who are taking part in clinical trials of other drugs and are known to be allergic to the treatment drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nucleic acid turning negative time;Nucleic acid conversion rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| rate to the light/normal;Time to change to the light/normal;Incidence of symptoms;Cumulative incidence of adverse events; | — |
Countries
China
Contacts
Public ContactLi Suyun
The First Affiliated Hospital to Henan University of Chinese Medicine
Outcome results
None listed